NanoZymeX

NanoZymeX is a nanobiotechnology startup dedicated to developing next-generation enzyme replacement therapies using proprietary lipid nanoparticles. Originating from research at the University of Basel, NanoZymeX integrates nanotechnology with protein therapy to enhance intracellular delivery, reduce immune responses, and enable targeted treatments for rare genetic diseases such as Pompe disease.